Sangamo Therapeutics Inc (SGMO)
0.553
+0.03
(+5.94%)
USD |
NASDAQ |
May 03, 16:00
0.553
0.00 (0.00%)
After-Hours: 18:55
Sangamo Therapeutics Cash from Operations (Quarterly): -50.54M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.54M |
| September 30, 2023 | -47.29M |
| June 30, 2023 | -60.71M |
| March 31, 2023 | -66.30M |
| December 31, 2022 | -57.05M |
| September 30, 2022 | -53.62M |
| June 30, 2022 | -53.98M |
| March 31, 2022 | -58.98M |
| December 31, 2021 | -52.71M |
| September 30, 2021 | -59.42M |
| June 30, 2021 | -52.57M |
| March 31, 2021 | -68.55M |
| December 31, 2020 | -4.295M |
| September 30, 2020 | 33.07M |
| June 30, 2020 | 159.99M |
| March 31, 2020 | -18.89M |
| December 31, 2019 | -20.82M |
| September 30, 2019 | -38.87M |
| June 30, 2019 | -39.59M |
| March 31, 2019 | -45.12M |
| December 31, 2018 | -40.16M |
| September 30, 2018 | -27.60M |
| June 30, 2018 | 122.44M |
| March 31, 2018 | -18.13M |
| December 31, 2017 | -16.84M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.69M |
| June 30, 2017 | 56.79M |
| March 31, 2017 | -13.08M |
| December 31, 2016 | -11.77M |
| September 30, 2016 | -17.58M |
| June 30, 2016 | -16.18M |
| March 31, 2016 | -20.36M |
| December 31, 2015 | -9.104M |
| September 30, 2015 | -14.20M |
| June 30, 2015 | -8.025M |
| March 31, 2015 | -2.393M |
| December 31, 2014 | -2.712M |
| September 30, 2014 | -5.768M |
| June 30, 2014 | -8.574M |
| March 31, 2014 | 11.38M |
| December 31, 2013 | -1.657M |
| September 30, 2013 | -4.514M |
| June 30, 2013 | -5.293M |
| March 31, 2013 | -8.018M |
| December 31, 2012 | 0.223M |
| September 30, 2012 | -5.159M |
| June 30, 2012 | -6.013M |
| March 31, 2012 | 2.867M |
| December 31, 2011 | 0.002M |
| September 30, 2011 | -6.468M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-68.55M
Minimum
Mar 2021
159.99M
Maximum
Jun 2020
-32.16M
Average
-52.57M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Electromed Inc | 3.471M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 37.71M |
| Cash from Financing (Quarterly) | 0.167M |
| Free Cash Flow | -246.00M |
| Free Cash Flow Per Share (Quarterly) | -0.2995 |
| Free Cash Flow to Equity (Quarterly) | -53.21M |
| Free Cash Flow to Firm (Quarterly) | -53.21M |
| Free Cash Flow Yield | -254.8% |